Suppr超能文献

隆突性皮肤纤维肉瘤:这是什么?

Dermatofibrosarcoma Protuberans: What Is This?

作者信息

Vitiello Gerardo A, Lee Ann Y, Berman Russell S

机构信息

Department of Surgery, Division of Surgical Oncology, New York University Langone Health, 550 First Avenue, NBV 15 North-1, New York, NY 10016, USA. Electronic address: https://twitter.com/GerardoVitiello.

Department of Surgery, Division of Surgical Oncology, New York University Langone Health, 550 First Avenue, NBV 15 North-1, New York, NY 10016, USA; Department of Surgery, Surgical Residency and Education Program, NYU Grossman School of Medicine, 160 East 34th Street, 7th Floor, New York, NY 10016, USA. Electronic address: https://twitter.com/AnnYLeeSurgOnc.

出版信息

Surg Clin North Am. 2022 Aug;102(4):657-665. doi: 10.1016/j.suc.2022.05.004.

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive dermal-based sarcoma. Metastatic potential is extremely low, primarily in the setting of fibrosarcomatous transformation. DFSP is characterized by a t(17;22) (q22;q13) translocation that results in active PDGFB signaling. Surgical resection with negative margins (typically including the underlying fascia) is the potentially curative treatment. Delayed wound closure should be considered for cases requiring extensive resection or tissue rearrangement. Tyrosine kinase inhibitors, such as imatinib, have shown response rates of 50% to 60% in patients with locally advanced or metastatic disease. Radiation can be useful for residual or recurrent diseases.

摘要

隆突性皮肤纤维肉瘤(DFSP)是一种罕见的、具有局部侵袭性的真皮源性肉瘤。转移潜能极低,主要发生在纤维肉瘤样转化的情况下。DFSP的特征是t(17;22)(q22;q13)易位,导致血小板衍生生长因子B(PDGFB)信号激活。切缘阴性的手术切除(通常包括深筋膜)是潜在的治愈性治疗方法。对于需要广泛切除或组织重排的病例,应考虑延迟伤口闭合。酪氨酸激酶抑制剂,如伊马替尼,在局部晚期或转移性疾病患者中的有效率为50%至60%。放疗对残留或复发性疾病可能有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验